Keywords: pharmacokinetics; obesity; pediatrics; proton pump inhibitors; AE; Adverse event; AUC; Area under the concentration time curve; AUCinf; AUC from time zero to infinity; AUClast; AUC from time zero to the time of the last measurable concentration; BMI; Body